Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Andreozzi, G.M.
Right arrow Articles by Martini, R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Andreozzi, G.M.
Right arrow Articles by Martini, R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


The fate of the claudicant limb

G.M. Andreozzi* and R. Martini

Angiology Care Unit, University Hospital of Padua, Padua, Italy

* Correspondence: Professor G.M. Andreozzi, Angiology Care Unit, University Hospital, via Giustiniani 2, 35 128 Padua, Italy.

Abstract

Intermittent claudication deteriorates in no more than 25% of patients. Distance walked on a treadmill is not a precise indicator of outcome, because the same impairment may result in severe limitation for one patient, but may not affect quality of life as judged by another. Only 18% of claudicant patients require surgical revascularization over 10 years, and smoking and ankle-brachial index are the most important markers of this type of surgery. Progression of claudication in critical leg ischaemia varies from 3.8% to 25% (5-year follow-up) and to 41% (8-year follow-up), and the amputation rate is approximately 10% (10-year follow-up). Inflammation and endothelial dysfunction appear to be the major risk factors for progression, but their occurrence is unpredictable and differs from patient to patient; consequently, further studies are required to clarify these aspects.

Key Words: Amputation • critical leg ischaemia • inflammation • intermittent claudication • peripheral arterial disease • treadmill

References

  1. Jelnes R, Gaardsting O, Hougard Jensen K, et al. Fate in intermittent claudication. Outcome and risk factors. BMJ. 1986;293:1137–1140
  2. Rosenbloom MS, Flaningam DP, Schuler JJ. Risk factors affecting the natural history of intermittent claudication. Arch Surg. 1988;123:867–869[Abstract/Free Full Text]
  3. O'Riordain DS, O'Donnell JA. Realistic expectations for the patient with intermittent claudication. Br J Surg. 1991;78:861–863[Web of Science][Medline]
  4. Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992;326:381–386[Abstract]
  5. Brevetti G, Martone VD, Perna S, et al. Intermittent claudication and risk of cardiovascular events. Angiology. 1998;49:843–848
  6. Imparato AM, Davidson T, Crowley JG. Intermittent claudication: its natural course. Surgery. 1975;78:795–799[Web of Science][Medline]
  7. Allister MC. The fate of patients with intermittent claudication managed non operatively. Am J Surg. 1976;132:875–883
  8. Cronenwett JL, Warner KG, Zeleneck GB, et al. intermittent claudication. Current results of non operative management. Arch Surg. 1984;119:430–436[Abstract/Free Full Text]
  9. Wilson SE, Schwartz I, Williams RA, Owens MI. Occlusion of the superficial femoral artery: what happens without operation? Am J Surg. 1980;140:112–118[CrossRef][Web of Science][Medline]
  10. Dormandy JA, Murray GD. The fate of the claudicant: a prospective study of 1969 claudicants. Eur J Vase Surg. 1991;5:131–133
  11. Leng GC. Questionnaires. Epidemiology of Peripheral Vascular Disease. London: Springer-Verlag; 1991. p. 29–40
  12. Barletta G, Perna S, Sabbà C, et al. Quality of life in patients with intermittent claudication. Relationship with laboratory exercise performance. Vase Med. 1996;1:3–7
  13. Hiatt WR, Hirsch AT, Regensteiner JG, et al. Clinical trials for claudication. Assessment of exercise performance, functional status, and clinical endpoint. Circulation. 1995;92:614–621[Free Full Text]
  14. Currie IC, Wilson YG, Baird RN, et al. Treatment of intermittent claudication. The impact on quality of life. Eur J Vasc Surg. 1995;10:356–361
  15. Gillum RE. Peripheral arterial occlusive disease of the extremities in the United States: hospitalisation and mortality. Am Heart J. 1990;120:1414–1418[CrossRef][Web of Science][Medline]
  16. US Dept of Health and Human Services. Detailed diagnosis and procedures: National Hospital Discharge Survey, 1990. Vital Health Stat. 1992;13:113
  17. Breslau PJ, Jorning PI, Dassen G. The natural history of intermittent claudication, a prospective study. Presented at II International Vascular Symposium. September 1986..
  18. Gilliand EL, Liewellyn CD, Goss DE, et al. The morbidity and mortality of stable claudicants: Results of five years follow-up. Presented at II International Vascular Symposium. September 1986.
  19. Muluk SC, Muluk VS, Kelley ME, et al. Outcome events in patients with claudication: a 15-year study in 2,777 patients. J Vasc Surg. 2001;33:251–257[CrossRef][Web of Science][Medline]
  20. Wolfe JHM. The definition of critical ischemia: is this concept of value? Greenhalgh RM, Jamieson CW, Nicolaides AN. Limb Salvage and Amputation for Vascular Disease. London: Saunders; 1988. p. 3–10
  21. Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery/North American Chapter, International Society for Cardiovascular Surgery. Suggested standards for reports dealing lower extremity ischemia. J Vasc Surg. 1986;4:80–94[CrossRef][Web of Science][Medline]
  22. Second European Consensus Document on chronic critical leg ischaemia. Eur J Vasc Surg. 1992;6(suppl A):1–32 Anonymous
  23. Wolfe JH, Wyatt MG. Critical and subcritical ischemia. Eur J Vase Endovasc Surg. 1997;13:578–582
  24. Catalano M. Epidemiology of critical limb ischemia: north Italian data. Eur J Med. 1993;2:11–14[Medline]
  25. The Vascular Surgical Society of Great Britain and Ireland. Critical limb ischemia: management and outcome. Report of a national survey. Eur J Vase Endovasc Surg. 1995;10:108–113
  26. Jonanson T, Ringquist J. Changes in peripheral blood pressures after 5 years of follow-up in non operated patients with intermittent claudication. Acta Med Scand. 1986;220:127–132[Web of Science][Medline]
  27. Daniel MC, Cronenwett JL. Basic data related to the natural history of intermittent claudication. Ann Vase Surg. 1986;3:273–277
  28. Kannel WB. Risk factors for atherosclerotic cardiovascular outcomes in different arterial territories. J Cardiovasc Risk. 1994;1:333–339[Medline]
  29. The I.C.A.I. Group. Long-term mortality and its predictors in patients with critical leg ischemia. Eur J Vasc Endovasc Surg. 1997;14:91–95[CrossRef][Web of Science][Medline]
  30. Bloor K. Natural history of atherosclerosis of the lower extremities. Ann Coll Surg Engl. 1996;28:36–51
  31. Da Silva A, Widmer LK, Zlegler HW, et al. The Basle longitudinal study. Report of the relation of the initial glucose level to baseline ECG abnormalities, peripheral arterial disease and subsequent mortality. J Chron Dis. 1979;32:797–808[CrossRef][Web of Science][Medline]
  32. Kannel WB, Skinner JJ, Schwartz MJ. Intermittent claudication incidence in Framingham study. Circulation. 1970;41:875–883[Abstract/Free Full Text]
  33. Dormandy JA, Belcher G, Broos P, et al. A prospective study of 713 below-knee amputations for ischemia and the effect of a prostacyclin analogue on healing. Br J Surg. 1994;81:33–37[Web of Science][Medline]
  34. Dormandy JA, Ray S. The natural history of peripheral arterial disease. Tooke JE, Lowe GD. A Textbook of Vascular Medicine. London: Arnold; 1996. p. 162–175
  35. Juergens JL, Barker NW, Hines FA. Atherosclerosis obliterans. Review of 520 cases with special reference to pathogenic and prognostic factors. Circulation. 1960;21:188–195[Abstract/Free Full Text]
  36. Lowe GDO, Fowkes FGR, Dawes J, et al. Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in Edinburgh Artery Study. Circulation. 1993;87:1915–1920[Abstract/Free Full Text]
  37. Dormandy JA, Hoore E, Colley J, et al. Clinical, haemodynamic, theological and biochemical findings in 126 patients with intermittent claudication. BMJ. 1973;4:576–581
  38. Langlois M, Duprez D, Delanghe J, et al. Serum vitamin C concentration is low in peripheral arterial disease and is associated with inflammation and severity of atherosclerosis. Circulation. 2001;103:1863–1868[Abstract/Free Full Text]
  39. Kirk G, Hickman P, McClaren M, et al. Interleukin-8 (IL-8) may contribute to the activation of neutrophils in patients with peripheral arterial occlusive disease. Eur J Vasc Endovasc Surg. 1999;18:434–438[CrossRef][Web of Science][Medline]
  40. Boger RH, Bode-Boger SM, Thiele W, et al. Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease. J Am Coll Cardiol. 1998;32:1236–1244
  41. Mustonen P, Lepantale M, Lassila R. Physical exertion induced thrombin formation and fibrin degradation in patients with peripheral atherosclerosis. Atheroscler Thromb Vasc Biol. 1998;18:244–249[Abstract/Free Full Text]
  42. Neumann FJ, Waas W, Diehm C, et al. Activation and decreased deformability of neutrophils after intermittent claudication. Circulation. 1990;82:922–929[Abstract/Free Full Text]
  43. Edwards AT, Blann AD, Suarez-Mendez VJ, et al. Systemic responses in patients with intermittent claudication after treadmill exercise. Br J Surgery. 1994;81:1738–1741[Web of Science][Medline]
  44. Libby P, Simon DI. Inflammation and thrombosis. The clot thickens. Circulation. 2001;103:1718–1720[Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Andreozzi, G.M.
Right arrow Articles by Martini, R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Andreozzi, G.M.
Right arrow Articles by Martini, R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?